Search research articles
Contact Us
Filters
Showing results (241-250 of 534) with videos related to
Page
of 54
Sort By:
Plos Pathogens
|
February 25, 2020
Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies
Thach H Chu, Andrew R Crowley, Iara Backes, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2022
Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19
Jonathan D Herman, Caroline Atyeo, Yonatan Zur, et al.
JCI Insight
|
June 20, 2020
Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune response
Stephanie Fischinger, Sally Shin, Carolyn M Boudreau, et al.
Open Forum Infectious Diseases
|
April 18, 2015
Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics
Jonathan Z Li, Kelly B Arnold, Janet Lo, et al.
Cell
|
December 13, 2022
Antibody effector functions are associated with protection from respiratory syncytial virus
Yannic C Bartsch, Deniz Cizmeci, Jaewon Kang, et al.
Scientific Reports
|
September 23, 2020
Unique repertoire of anti-carbohydrate antibodies in individual human serum
Ralph N D Luetscher, Tanya R McKitrick, Chao Gao, et al.
Immunity
|
January 23, 2016
Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions
Bruce T Schultz, Jeffrey E Teigler, Franco Pissani, et al.
Plos One
|
April 12, 2022
Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center
Jeffrey A Meyerhardt, Hong Yue, Radosław P Nowak, et al.
Science Translational Medicine
|
March 15, 2022
Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines
Yannic C Bartsch, Xin Tong, Jaewon Kang, et al.
The Journal of Infectious Diseases
|
August 31, 2006
Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection
Hendrik Streeck, Heiko Jessen, Galit Alter, et al.
Page
of 54
Search research articles
Search
Showing results (241-250 of 534) with videos related to
Sort By:
Page
of 54
Plos Pathogens
|
February 25, 2020
Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies
Thach H Chu, Andrew R Crowley, Iara Backes, et al.
Medrxiv : the Preprint Server for Health Sciences
|
October 7, 2022
Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19
Jonathan D Herman, Caroline Atyeo, Yonatan Zur, et al.
JCI Insight
|
June 20, 2020
Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune response
Stephanie Fischinger, Sally Shin, Carolyn M Boudreau, et al.
Open Forum Infectious Diseases
|
April 18, 2015
Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics
Jonathan Z Li, Kelly B Arnold, Janet Lo, et al.
Cell
|
December 13, 2022
Antibody effector functions are associated with protection from respiratory syncytial virus
Yannic C Bartsch, Deniz Cizmeci, Jaewon Kang, et al.
Scientific Reports
|
September 23, 2020
Unique repertoire of anti-carbohydrate antibodies in individual human serum
Ralph N D Luetscher, Tanya R McKitrick, Chao Gao, et al.
Immunity
|
January 23, 2016
Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions
Bruce T Schultz, Jeffrey E Teigler, Franco Pissani, et al.
Plos One
|
April 12, 2022
Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center
Jeffrey A Meyerhardt, Hong Yue, Radosław P Nowak, et al.
Science Translational Medicine
|
March 15, 2022
Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines
Yannic C Bartsch, Xin Tong, Jaewon Kang, et al.
The Journal of Infectious Diseases
|
August 31, 2006
Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection
Hendrik Streeck, Heiko Jessen, Galit Alter, et al.
Page
of 54